Inventor · disambiguated record
Kirstin Petersen
Also filed as: PETERSEN KIRSTIN
16 granted patents·14 pending applications·15 citations·filing 2008–2022
87Inventor score
Top patents by PatentIndex Score
30 records- 0188US11998539B2Substituted aminoquinolones as DGKalpha inhibitors for immune activationBAYER AG·Filed 2022·Granted Jun 4, 2024·1 cites·24 claims
- 0280US9382255B2Substituted pyrrolopyrimidinylamino-benzothiazolones as MKNK kinase inhibitorsBayer Pharma AG·Filed 2013·Granted Jul 5, 2016·3 cites·9 claims
- 0378US10214542B2Modified macrocyclic compoundsBayer Pharma AG·Filed 2016·Granted Feb 26, 2019·2 cites·27 claims
- 0477US10717749B2Macrocyclic sulfondiimine compoundsBayer Pharma AG·Filed 2016·Granted Jul 21, 2020·2 cites·17 claims
- 0575US11964953B2Substituted aminothiazoles as DGKzeta inhibitors for immune activationBAYER AG·Filed 2022·Granted Apr 23, 2024·0 cites·26 claims
- 0675US9409889B2Amino-substituted imidazopyridazinesBayer Pharma AG·Filed 2013·Granted Aug 9, 2016·3 cites·9 claims
- 0774US11339157B14H-pyrrolo[3,2-c]pyridin-4-one derivativesBAYER AG·Filed 2018·Granted May 24, 2022·2 cites·19 claims
- 0868US11427578B1Substituted pyrrolopyridine-derivativesBayer Pharma AG·Filed 2018·Granted Aug 30, 2022·1 cites·18 claims
- 0966US10487092B2Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitorsBayer Pharma AG·Filed 2015·Granted Nov 26, 2019·1 cites·22 claims
- 1062US2023167078A1Substituted aminothiazoles as dgkzeta inhibitors for immune activationBAYER AG·Filed 2021·Application pending·0 cites
- 1160US2023167103A1Substituted aminothiazoles as dgkzeta inhibitors for immune activationBAYER AG·Filed 2021·Application pending·0 cites
- 1257US12478621B2Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Granted Nov 25, 2025·0 cites·17 claims
- 1354US2009082328A1Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityBAYER HEALTHCARE AG·Filed 2008·Application pending·0 cites
- 1453US2022235013A12-methyl-quinazolinesBayer Pharma AG·Filed 2018·Application pending·0 cites
- 1550US2015252047A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseasesBayer Pharma AG·Filed 2013·Application pending·0 cites
- 1650US2023064809A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 1749US2011071125A1Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activityRUDOLPH JOACHIM·Filed 2008·Application pending·0 cites
- 1848US2023062100A1Substituted aminoquinolones as dgkalpha inhibitors for immune activationBAYER AG·Filed 2020·Application pending·0 cites
- 1945US8524722B2Substituted tricyclic compounds and methods of use thereofSCHIROK HARTMUT·Filed 2008·Granted Sep 3, 2013·0 cites·20 claims
- 2045US2016297833A1Thienopyrimidines as mknk1 and mknk2 inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2144US2016287589A1Substituted-imidazopyridazinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2244US2016159789A1Substituted pyrazolopyridinesBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2343US9783543B2AminoimidazopyridazinesBayer Pharma AG·Filed 2013·Granted Oct 10, 2017·0 cites·8 claims
- 2443US9745304B2Amidoimidazopyridazines as MKNK-1 kinase inhibitorsBayer Pharma AG·Filed 2014·Granted Aug 29, 2017·0 cites·9 claims
- 2542US9777004B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2013·Granted Oct 3, 2017·0 cites·9 claims
- 2642US2015218173A1Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disordersBayer Pharma AG·Filed 2013·Application pending·0 cites
- 2741US9643974B2Amino-substituted imidazopyridazinesBAYER IP GMBH·Filed 2012·Granted May 9, 2017·0 cites·9 claims
- 2836US2018022750A16-hydroxybenzofuranyl- and 6-alkoxybenzofuranyl-substituted imidazopyridazinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 2935US10214545B2Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disordersBayer Pharma AG·Filed 2015·Granted Feb 26, 2019·0 cites·21 claims
- 3032US2017107229A1Substituted tetrahydropyridothienopyrimidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kirstin Petersen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →